JEMQX
Price
$10.04
Change
+$0.01 (+0.10%)
Updated
Jun 6 closing price
Net Assets
1.29B
RNWBX
Price
$81.94
Change
+$0.18 (+0.22%)
Updated
Jun 6 closing price
Net Assets
67.63B
Interact to see
Advertisement

JEMQX vs RNWBX

Header iconJEMQX vs RNWBX Comparison
Open Charts JEMQX vs RNWBXBanner chart's image
JHancock Emerging Markets Equity A
Price$10.04
Change+$0.01 (+0.10%)
VolumeN/A
Net Assets1.29B
American Funds New World R2
Price$81.94
Change+$0.18 (+0.22%)
VolumeN/A
Net Assets67.63B
JEMQX vs RNWBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JEMQX vs. RNWBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JEMQX is a Buy and RNWBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWBX has more cash in the bank: 67.6B vs. JEMQX (1.29B). RNWBX pays higher dividends than JEMQX: RNWBX (0.13) vs JEMQX (0.12). JEMQX was incepted earlier than RNWBX: JEMQX (10 years) vs RNWBX (23 years). RNWBX (1.67) is less costly to investors than JEMQX (1.47). JEMQX is a more actively managed with annual turnover of: 46.00 vs. RNWBX (37.00). RNWBX has a lower initial minimum investment than JEMQX: RNWBX (250) vs JEMQX (1000). JEMQX annual gain was more profitable for investors over the last year : 7.41 vs. RNWBX (6.57). RNWBX return over 5 years is better than : 25.37 vs. JEMQX (-8.04).
JEMQXRNWBXJEMQX / RNWBX
Total Expense Ratio1.311.6778%
Annual Report Gross Expense Ratio1.471.6788%
Fund Existence10 years23 years-
Gain YTD6.02511.40753%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.29B67.6B2%
Annual Yield % from dividends0.120.1392%
Returns for 1 year7.416.57113%
Returns for 3 years5.2621.1225%
Returns for 5 years-8.0425.37-32%
Returns for 10 yearsN/A55.86-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV6.200.47
+8.12%
Verve Therapeutics
IOBT1.600.10
+6.67%
IO Biotech
SHO8.770.12
+1.39%
Sunstone Hotel Investors
SGI65.450.62
+0.96%
Somnigroup International Inc.
ASTI1.62N/A
N/A
Ascent Solar Technologies Inc